The Hospital Medicine Safety Consortium is focused on evaluating and improving the care of hospitalized medical patients who are at risk for hospital-associated infections or blood clots. More than 40 hospitals and 10,000 physicians participate in this consortium.
For more information, go to mi-hms.org
- Improvement in the rates of VTE risk assessment, appropriate prophylaxis for high-risk patients, and prophylaxis avoided for low-risk patients.
- Increase in use of single lumen PICCs, decrease in short term PICC use, and decrease in PICC use for patients with chronic kidney disease (eGFR <45).
- Decrease in urine culture testing in patients without symptoms of a UTI, decrease in antibiotic therapy in patients without symptoms of a UTI, and increase in appropriate duration of therapy for patients with community acquired pneumonia.